Skip to main content

Table 1 Synergy assessment in differentially expressed genes identified in the nCounter gene expression studies

From: The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors

  1. + Indicates gene expression is significantly different from that in the vehicle control
  2. (red) indicates a significant difference between the combination treatment and both single-agent treatments
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us